Androgen Deprivation Therapy Toxicity and Management for Men Receiving Radiation Therapy

by Matthew E. Johnson, Mark K. Buyyounouski
Published 2012-01-01

Development and Validation of an Interpretable Artificial Intelligence Model to Predict 10-Year Prostate Cancer Mortality

by Jean-Emmanuel Bibault, Steven Hancock, Mark K. Buyyounouski, Hilary Bagshaw, John T. Leppert, Joseph C. Liao, Lei Xing
Published 2021-06-01

Results from a Phase 1 Study of Sodium Selenite in Combination with Palliative Radiation Therapy in Patients with Metastatic Cancer

by Susan J. Knox, Priya Jayachandran, Christine A. Keeling, Kathryn J. Stevens, Navjot Sandhu, Stacy Leanne Stamps-DeAnda, Rada Savic, Lei Shura, Mark K. Buyyounouski, Kevin Grimes
Published 2019-11-01

Toxicity After Stereotactic Body Radiation Therapy for Prostate Cancer in Patients With Inflammatory Bowel Disease: A Multi-institutional Matched Case-Control Series

by Jesus E. Juarez, MD, Tahmineh Romero, MS, Constantine A. Mantz, MD, Abigail Pepin, MD, Nima Aghdam, MD, Simeng Suy, PhD, Michael L. Steinberg, MD, Rebecca G. Levin-Epstein, MD, Nicholas G. Nickols, MD, PhD, Irving D. Kaplan, MD, Robert M. Meier, MD, Huong T. Pham, MD, Patrick W. Linson, MD, Robert L. Hong, MD, Mark K. Buyyounouski, MD, Hilary P. Bagshaw, MD, Donald B. Fuller, MD, Alan J. Katz, MD, Andrew Loblaw, MD, Sean P. Collins, MD, PhD, Amar U. Kishan, MD
Published 2021-11-01